Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
about
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis InfectionIsoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysisEvaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
P2860
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Self-administered Versus Direc ...... Infection: A Randomized Trial.
@en
Self-administered Versus Direc ...... Infection: A Randomized Trial.
@nl
type
label
Self-administered Versus Direc ...... Infection: A Randomized Trial.
@en
Self-administered Versus Direc ...... Infection: A Randomized Trial.
@nl
prefLabel
Self-administered Versus Direc ...... Infection: A Randomized Trial.
@en
Self-administered Versus Direc ...... Infection: A Randomized Trial.
@nl
P2093
P2860
P356
P1476
Self-administered Versus Direc ...... Infection: A Randomized Trial.
@en
P2093
Alicia Wright
Andrey S Borisov
Bert Arevalo
David Holland
Joan A Caylà
Joan-Pau Millet
José M Miró
Marc Weiner
Margarita E Villarino
Michael P Chen
P2860
P304
P356
10.7326/M17-1150
P407
P577
2017-11-07T00:00:00Z